1. Home
  2. HBCP vs ESPR Comparison

HBCP vs ESPR Comparison

Compare HBCP & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Home Bancorp Inc.

HBCP

Home Bancorp Inc.

HOLD

Current Price

$62.70

Market Cap

453.4M

Sector

Finance

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$2.31

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBCP
ESPR
Founded
1908
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
453.4M
731.9M
IPO Year
2008
2013

Fundamental Metrics

Financial Performance
Metric
HBCP
ESPR
Price
$62.70
$2.31
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$63.50
$7.60
AVG Volume (30 Days)
123.2K
5.5M
Earning Date
04-20-2026
05-05-2026
Dividend Yield
1.98%
N/A
EPS Growth
29.01
60.71
EPS
5.87
N/A
Revenue
N/A
$403,135,000.00
Revenue This Year
N/A
$2.92
Revenue Next Year
$4.74
N/A
P/E Ratio
$10.68
N/A
Revenue Growth
N/A
21.31
52 Week Low
$40.74
$0.73
52 Week High
$64.17
$4.18

Technical Indicators

Market Signals
Indicator
HBCP
ESPR
Relative Strength Index (RSI) 61.22 33.99
Support Level $56.27 $1.02
Resistance Level $64.12 $3.02
Average True Range (ATR) 1.91 0.20
MACD 0.28 0.00
Stochastic Oscillator 91.16 17.40

Price Performance

Historical Comparison
HBCP
ESPR

About HBCP Home Bancorp Inc.

Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities.It is holding company for Home Bank, N.A. The principal sources of funds are customer deposits, repayments of loans, repayments of investments, and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

Share on Social Networks: